Board-certified radiologist final signed reports for a cash-pay functional medicine clinic. Priced per report, with no minimum and no platform fee.
Quinn Functional Health opens 31 August 2026 as a cash-pay, membership-model functional medicine clinic. You see the stage three and four oncology patients yourself; your PAs see everyone else. Patients move through advanced testing, nutrition and therapy, then return three to four weeks later.
You bought a Butterfly IQ3 to scan at the point of care, and you are RVT and ARRT(S) credentialed, so scanning is not the problem. What you need is the other half: an official report signed by a US board-certified radiologist that a patient's oncologist will not question.
Every study returns structured — history, technique, findings, numbered impression — electronically signed by the reading radiologist with name and credentials. No preliminary tier. The value is not that a report exists, it is whose name is on it: a report signed by an American Board of Radiology certified radiologist is the version an oncologist puts in a chart.
General and limited vascular ultrasound, read and signed as final diagnostic reports, from the exam mix you described. Anything excluded is covered by the same panel and rate ladder; adding it later is an email, not a new contract.
| Scope | Typical exams |
|---|---|
| Abdominal | Complete and limited abdomen, liver, biliary, renal, retroperitoneal |
| Small parts | Thyroid and soft tissue neck, scrotal, superficial masses |
| Pelvic | Prostate and bladder, transabdominal, complete or limited |
| Vascular | Carotid duplex, lower extremity venous duplex for DVT |
| Out of scope | Transvaginal, obstetric, musculoskeletal, echocardiography, at your request. Prostate work is transabdominal (the IQ3 has no endocavitary probe). |
Before you build carotid screening into a wellness panel: the USPSTF recommends against it in asymptomatic adults with no history of stroke or TIA. Paying cash removes the coverage argument, not the standard-of-care one, and an incidental finding on a study you did not need creates a workup you then own. Carotid duplex on a symptomatic patient is a different conversation, and we read those all day.
Butterfly IQ3 at the point of care, as planned. Studies land in Butterfly Cloud with patient demographics and your worksheet attached.
Which of two routes applies depends on your Butterfly subscription — better set out now than discovered during onboarding.
Organization plan: automatic DICOM forwarding from Butterfly Cloud to the AstraRad PACS, via Butterfly's own PACS/VNA Integrations feature, which is genuinely good. Studies forward as you finalise them; you upload nothing and never tell us a scan is ready.
Individual plan: forwarding is not included, so we add our radiologist to your Butterfly Cloud organisation as a member and they read in place. No new software, no cost, works from day one.
Routed by body part to a board-certified radiologist licensed in Texas, read, and signed as a final report.
Delivered to your secure AstraRad portal as a clean printable PDF, ready to attach to a chart or hand to a referring specialist.
We checked this rather than telling you it should be fine. Cerbo publishes a documented API for pushing documents straight into a patient chart, and we deliver signed report PDFs through it.
Cerbo is not ONC-certified and offers no FHIR, so the document API is the right path. Their HL7 lab-results feed exists, but it carries a setup fee, multi-week timelines and a design built around lab volume, so we would not start there. Portal PDF delivery works from the first study regardless, so nothing waits on this; we confirm the API against your tenant at onboarding.
You get a small named reading group rather than an anonymous queue, plus a direct line for case discussion. If you want to talk a finding through before you see the patient, that call gets set up. Most low-cost per-click services do not offer this at all.
You are RVT and ARRT(S), so this will be familiar. Each study needs the standard technologist worksheet: indication and history, measurements, laterality, and anything you saw at the bedside the images will not show. For vascular, the usual velocity and waveform documentation. We send templates at onboarding; if you prefer your own, we read from yours.
Agree the vascular protocol up front. Carotid duplex under the ACR parameter expects angle-corrected peak-systolic and end-diastolic velocities at multiple levels on each side — materially heavier than a general abdominal study, and the one place a handheld probe needs deliberate technique. Your IQ3's presets support angle correction, so this is a protocol conversation, not an equipment problem — but it is the piece most worth walking through together before your first carotid, and we would rather set it with you than send a report back asking for repeat views.
Contractual, not an average we hope to hit. Miss a tier on a study and that study carries a per-report credit.
Across our whole book, 99.4% of reports landed inside their SLA tier over the trailing 12 months, and median STAT turnaround is 28 minutes, measured monthly.
Your real turnaround requirement is the visit cycle, not the clock.
You told us this is not a STAT situation and that two to three weeks would be fine, because the report only has to be in hand when the patient returns. We are quoting under 24 hours anyway: the imaging report is then never the thing holding up a visit, and if a scan turns up something that changes a plan, you know the same day rather than three weeks later.
Five signed reports at no charge, on real studies, so you see the format, the turnaround and the workflow before any money changes hands. Full final signed reports, not samples — usable clinically. Billing starts at report six: one itemised monthly invoice, or a prepaid wallet.
| Volume / month | Per report | Tier |
|---|---|---|
| Up to 100 | $44 | Yours |
| 101 – 200 | $39 | — |
| 201 – 500 | $33 | — |
| 500+ | $29 | — |
The ladder moves automatically: cross a tier and the lower rate applies that month. No commitment, no renegotiation. Scan more than the 40 to 50 you quoted and the price follows you down.
| Scenario | Studies | Rate | Monthly |
|---|---|---|---|
| Your stated low end | 40 | $44 | $1,760 |
| Your stated high end | 50 | $44 | $2,200 |
| First month, after 5 free | 50 | $44 | $1,980 |
| If you grow past 100 | 120 | $39 | $4,680 |
A fair question — you already have friends quoting $25. The work inside a report does not get cheaper with volume: the read, the routing, the peer-review sampling, the Texas licensure, the malpractice cover and the signature cost the same at 40 a month as at 400. Volume only changes how far fixed cost spreads, and the ladder is the published shape of that. So compare what is attached to the number. At $25 a scan, ask:
A preliminary read that still needs finalising is not cheaper, it is a second invoice. On DocPanel: the only price they publish is $199 per study, for consumer second-opinion reads. Practice pricing is not published, so you cannot compare us until they put a number in writing.
For context: AstraRad handles 600,000 reads a year across 240 board-certified subspecialists in ten subspecialties, 24/7/365 across 12 time zones, with room for 25,000 additional studies a month and no waitlist. A 40 to 50 study month is not a volume we need you to justify.
First signed report within 10 business days of countersignature. The only dependency on your side is the Butterfly Cloud setup. De-identified sample reports follow separately, as Abhijeet promised.
First, the diagnostic study needs a licensed practitioner as the ordering provider — most naturally your PAs, under their delegated authority — worth writing into your protocol before the first scan. Second, Texas has a corporate-practice-of-medicine doctrine governing how a business not owned by a physician handles a physician's professional fee, and a cash-pay clinic charging a price that includes a radiologist's interpretation is exactly that fact pattern. Well-trodden structures exist; both are worth a short call with your attorney.
Signing authorises AstraRad to begin onboarding on the terms set out here. It is not a volume commitment: it starts the work, and you can stop month-to-month with 60 days' notice. If anything here does not match the call, tell us and we will correct the document.
RAFAEL VIEIRA CHIEF EXECUTIVE OFFICER HELLO@ASTRARAD.COM
ABHIJEET R. CHIEF OPERATING OFFICER ASTRARAD.COM